- Supported exchanges /
- JK /
- DVLA.JK
Darya-Varia Laboratoria Tbk (DVLA JK) stock market data APIs
PT Darya-Varia Laboratoria Tbk engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company provides prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic medicine, somatik, ear healthcare, and central nerve systems. It also offers Consumer Health products comprising Skin Nutrition under the Natur-E brand; Respiratory products under the Decolgen, ALLERIN EXPECTORANT, Decolsin, NEOZEP, STOP COLD, SILEX, and HERBABLEND brand names for nasal congestion, cough, as well as breathing issues caused by allergy; multivitamins under the Enervon-C, Enervon Active, Enervon Gold, and Supertin brands; vitamin C under the Vicee brand; and supplement for kids with Zinc and vitamin C under the Imunped brand; Biogesic for various types of pain; Diatabs, a anti diarrhea product; and New Enzyplex to prevent indigestion. In addition, the company offers toll manufacturing services for soft gelatin capsules, and sterile injections and low volume solid products. It also exports its products to Malaysia, Myanmar, the Philippines, Singapore, Vietnam, and Mongolia. The company was founded in 1976 and is headquartered in Jakarta, Indonesia. PT Darya-Varia Laboratoria Tbk is a subsidiary of Blue Sphere Singapore Pte. Ltd.
Darya-Varia Laboratoria Tbk Financial Data Overview
1635 | |
1635 | |
- | |
1645 | |
1630 | |
1288.5616-1806.1708 | |
1 831 200 M | |
9.3987 | |
1 120 M | |
2 134 031 M | |
31.6051 | |
0.0661 | |
-0.096 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Darya-Varia Laboratoria Tbk Fundamental Data is available in our Financial Data APIs
- Net Revenue 2 134 031 M
- EBITDA 307 788 M
- Earnings Per Share 173.96
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Darya-Varia Laboratoria Tbk Earnings via APIs
- Latest Release 2023-07-28
- EPS/Forecast NaN
Get Darya-Varia Laboratoria Tbk End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: